A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Clinical trial NCT02861534 · COMPLETED
Trial details
- NCT number
- NCT02861534
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-20
- Primary completion
- 2019-06-18
- Enrollment
- 5050
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.